SHANNON O'BRIEN: Open Payments
NPI 1154567675 · SEWELL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,150 in 63 payments from 19 companies in 2025. Trend: 2023 $1,120 · 2024 $1,257 · 2025 $1,150
Food & beverage: $1,150
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $185 |
| Insulet Corporation | 6 | $161 |
| Abbott Laboratories | 12 | $149 |
| Amphastar Pharmaceuticals, Inc. | 6 | $102 |
| Novo Nordisk Inc | 5 | $94 |
| Madrigal Pharmaceuticals | 4 | $85 |
| BETA BIONICS, INC. | 3 | $74 |
| Sequel Med Tech, LLC | 2 | $46 |
| Tandem Diabetes Care, Inc. | 2 | $42 |
| Amgen Inc. | 2 | $33 |
Products named: Omnipod, FREESTYLE LIBRE 3, MOUNJARO, REZDIFFRA, JARDIANCE, iLet Bionic Pancreas, Rybelsus, TWIIST.
Industry payments across NJ — which companies pay providers there.
